301 related articles for article (PubMed ID: 31844279)
21. Expression and localization of nuclear proteins in autosomal-dominant Emery-Dreifuss muscular dystrophy with LMNA R377H mutation.
Reichart B; Klafke R; Dreger C; Krüger E; Motsch I; Ewald A; Schäfer J; Reichmann H; Müller CR; Dabauvalle MC
BMC Cell Biol; 2004 Mar; 5():12. PubMed ID: 15053843
[TBL] [Abstract][Full Text] [Related]
22. Suppression of myopathic lamin mutations by muscle-specific activation of AMPK and modulation of downstream signaling.
Chandran S; Suggs JA; Wang BJ; Han A; Bhide S; Cryderman DE; Moore SA; Bernstein SI; Wallrath LL; Melkani GC
Hum Mol Genet; 2019 Feb; 28(3):351-371. PubMed ID: 30239736
[TBL] [Abstract][Full Text] [Related]
23. Expression of lamin A mutated in the carboxyl-terminal tail generates an aberrant nuclear phenotype similar to that observed in cells from patients with Dunnigan-type partial lipodystrophy and Emery-Dreifuss muscular dystrophy.
Favreau C; Dubosclard E; Ostlund C; Vigouroux C; Capeau J; Wehnert M; Higuet D; Worman HJ; Courvalin JC; Buendia B
Exp Cell Res; 2003 Jan; 282(1):14-23. PubMed ID: 12490190
[TBL] [Abstract][Full Text] [Related]
24. Need for NAD
Cardoso D; Muchir A
Cells; 2020 Oct; 9(10):. PubMed ID: 33036437
[TBL] [Abstract][Full Text] [Related]
25. Myopathic lamin mutations cause reductive stress and activate the nrf2/keap-1 pathway.
Dialynas G; Shrestha OK; Ponce JM; Zwerger M; Thiemann DA; Young GH; Moore SA; Yu L; Lammerding J; Wallrath LL
PLoS Genet; 2015 May; 11(5):e1005231. PubMed ID: 25996830
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins.
Muchir A; Shan J; Bonne G; Lehnart SE; Worman HJ
Hum Mol Genet; 2009 Jan; 18(2):241-7. PubMed ID: 18927124
[TBL] [Abstract][Full Text] [Related]
27. Pathology and nuclear abnormalities in hearts of transgenic mice expressing M371K lamin A encoded by an LMNA mutation causing Emery-Dreifuss muscular dystrophy.
Wang Y; Herron AJ; Worman HJ
Hum Mol Genet; 2006 Aug; 15(16):2479-89. PubMed ID: 16825283
[TBL] [Abstract][Full Text] [Related]
28. Deletion of the LMNA initiator codon leading to a neurogenic variant of autosomal dominant Emery-Dreifuss muscular dystrophy.
Walter MC; Witt TN; Weigel BS; Reilich P; Richard P; Pongratz D; Bonne G; Wehnert MS; Lochmüller H
Neuromuscul Disord; 2005 Jan; 15(1):40-4. PubMed ID: 15639119
[TBL] [Abstract][Full Text] [Related]
29. SMAD6 overexpression leads to accelerated myogenic differentiation of LMNA mutated cells.
Janin A; Bauer D; Ratti F; Valla C; Bertrand A; Christin E; Chopin E; Streichenberger N; Bonne G; Gache V; Cohen T; Méjat A
Sci Rep; 2018 Apr; 8(1):5618. PubMed ID: 29618840
[TBL] [Abstract][Full Text] [Related]
30. The non-muscle ADF/cofilin-1 controls sarcomeric actin filament integrity and force production in striated muscle laminopathies.
Vignier N; Chatzifrangkeskou M; Pinton L; Wioland H; Marais T; Lemaitre M; Le Dour C; Peccate C; Cardoso D; Schmitt A; Wu W; Biferi MG; Naouar N; Macquart C; Beuvin M; Decostre V; Bonne G; Romet-Lemonne G; Worman HJ; Tedesco FS; Jégou A; Muchir A
Cell Rep; 2021 Aug; 36(8):109601. PubMed ID: 34433058
[TBL] [Abstract][Full Text] [Related]
31. "Laminopathies": a wide spectrum of human diseases.
Worman HJ; Bonne G
Exp Cell Res; 2007 Jun; 313(10):2121-33. PubMed ID: 17467691
[TBL] [Abstract][Full Text] [Related]
32. Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations.
Muchir A; Medioni J; Laluc M; Massart C; Arimura T; van der Kooi AJ; Desguerre I; Mayer M; Ferrer X; Briault S; Hirano M; Worman HJ; Mallet A; Wehnert M; Schwartz K; Bonne G
Muscle Nerve; 2004 Oct; 30(4):444-50. PubMed ID: 15372542
[TBL] [Abstract][Full Text] [Related]
33. Dysfunctional polycomb transcriptional repression contributes to lamin A/C-dependent muscular dystrophy.
Bianchi A; Mozzetta C; Pegoli G; Lucini F; Valsoni S; Rosti V; Petrini C; Cortesi A; Gregoretti F; Antonelli L; Oliva G; De Bardi M; Rizzi R; Bodega B; Pasini D; Ferrari F; Bearzi C; Lanzuolo C
J Clin Invest; 2020 May; 130(5):2408-2421. PubMed ID: 31999646
[TBL] [Abstract][Full Text] [Related]
34. Eliminating elevated p53 signaling fails to rescue skeletal muscle defects or extend survival in lamin A/C-deficient mice.
Kirby TJ; Zahr HC; Fong EHH; Lammerding J
Cell Death Discov; 2024 May; 10(1):245. PubMed ID: 38778055
[TBL] [Abstract][Full Text] [Related]
35. Does satellite cell dysfunction contribute to disease progression in Emery-Dreifuss muscular dystrophy?
Gnocchi VF; Ellis JA; Zammit PS
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1344-9. PubMed ID: 19021553
[TBL] [Abstract][Full Text] [Related]
36. [Laminopathies. Nuclear lamina diseases].
Méndez-López I
Med Clin (Barc); 2012 Mar; 138(5):208-14. PubMed ID: 21632068
[TBL] [Abstract][Full Text] [Related]
37. Emery-Dreifuss muscular dystrophy.
Muchir A; Worman HJ
Curr Neurol Neurosci Rep; 2007 Jan; 7(1):78-83. PubMed ID: 17217858
[TBL] [Abstract][Full Text] [Related]
38. Both lamin A and lamin C mutations cause lamina instability as well as loss of internal nuclear lamin organization.
Broers JL; Kuijpers HJ; Ostlund C; Worman HJ; Endert J; Ramaekers FC
Exp Cell Res; 2005 Apr; 304(2):582-92. PubMed ID: 15748902
[TBL] [Abstract][Full Text] [Related]
39. Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan.
Astejada MN; Goto K; Nagano A; Ura S; Noguchi S; Nonaka I; Nishino I; Hayashi YK
Acta Myol; 2007 Dec; 26(3):159-64. PubMed ID: 18646565
[TBL] [Abstract][Full Text] [Related]
40. Lamins A and C are differentially dysfunctional in autosomal dominant Emery-Dreifuss muscular dystrophy.
Motsch I; Kaluarachchi M; Emerson LJ; Brown CA; Brown SC; Dabauvalle MC; Ellis JA
Eur J Cell Biol; 2005 Sep; 84(9):765-81. PubMed ID: 16218190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
